Status and treatment of patients with uterine fibroids in hospitals in central China: a retrospective study from 2018 to 2021

Objective To evaluate the hospitalised patients with uterine fibroids (UFs) and describe treatment patterns in hospital-treated patients in central China from 2018 to 2021.Design A retrospective analysis.Setting The gynaecology departments of class A and class B secondary and tertiary hospitals in H...

Full description

Saved in:
Bibliographic Details
Main Authors: Wei Yan, Shixuan Wang, Minli Zhang, Wenwen Wang, Da Zhou, Suzhen Yuan, Shuhao Yang
Format: Article
Language:English
Published: BMJ Publishing Group 2024-01-01
Series:BMJ Open
Online Access:https://bmjopen.bmj.com/content/14/1/e081736.full
Tags: Add Tag
No Tags, Be the first to tag this record!
_version_ 1850196031902318592
author Wei Yan
Shixuan Wang
Minli Zhang
Wenwen Wang
Da Zhou
Suzhen Yuan
Shuhao Yang
author_facet Wei Yan
Shixuan Wang
Minli Zhang
Wenwen Wang
Da Zhou
Suzhen Yuan
Shuhao Yang
author_sort Wei Yan
collection DOAJ
description Objective To evaluate the hospitalised patients with uterine fibroids (UFs) and describe treatment patterns in hospital-treated patients in central China from 2018 to 2021.Design A retrospective analysis.Setting The gynaecology departments of class A and class B secondary and tertiary hospitals in Hubei Province, China.Participants 101 008 patients diagnosed with UFs from 1 January 2018 to 31 December 2021.Results The hospitalised patients with UFs increased with age, reaching a peak at ages 45–49 years and then gradually decreasing. Among these patients, 19.05% had anaemia symptoms. Women aged 25–29 years were more likely to be treated with laparoscopic myomectomy (62.22%), while women aged 20–24 years tend to choose open myomectomy (34.58%). Women over age 45 years who had entered perimenopause tended to be treated with laparoscopic hysterectomy (64.85% for those aged 65–69 years). Patients with fibroid with moderate-to-severe anaemia mostly chose hysterectomy. As a whole, the proportion of patients who chose laparoscopic hysterectomy was similar to that of patients who chose laparoscopic myomectomy (31.38% vs 31.14%). Only 2.08% of UFs were treated with high-frequency MRI-guided focused ultrasound surgery (MRgFUS). The number of patients who choose laparoscopic surgery or MRgFUS treatment was increasing year by year. After stratifying by hospital grade, we found that women treated at class A tertiary hospitals were more likely to have laparoscopic than open surgery (66.12% vs 31.26%). At class B secondary hospitals, 61.9% of the patients underwent myomectomy. By contrast, hysterectomy was used to treat the majority of patients at class A secondary hospitals and class B tertiary hospitals (57.79% and 57.57%, respectively). Use of MRgFUS was mainly concentrated within class A tertiary hospitals.Conclusion UFs affect mainly women in childbearing period. Most patients chose to receive treatment at class A tertiary hospitals, among which laparoscopic myomectomy was the mainstream surgical method for patients in Hubei Province.Trial registration number NCT05840042.
format Article
id doaj-art-3be8bfa8c12b4949a2b39301d0f29f21
institution OA Journals
issn 2044-6055
language English
publishDate 2024-01-01
publisher BMJ Publishing Group
record_format Article
series BMJ Open
spelling doaj-art-3be8bfa8c12b4949a2b39301d0f29f212025-08-20T02:13:35ZengBMJ Publishing GroupBMJ Open2044-60552024-01-0114110.1136/bmjopen-2023-081736Status and treatment of patients with uterine fibroids in hospitals in central China: a retrospective study from 2018 to 2021Wei Yan0Shixuan Wang1Minli Zhang2Wenwen Wang3Da Zhou4Suzhen Yuan5Shuhao Yang66Sound Biologics, Bothell, WA, USADepartment of Obstetrics and Gynecology, National Clinical Research Center for Obstetrics and Gynecology, Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, ChinaDepartment of Obstetrics and Gynecology, National Clinical Research Center for Obstetrics and Gynecology, Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, ChinaDepartment of Obstetrics and Gynecology, National Clinical Research Center for Obstetrics and Gynecology, Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, ChinaHealth Commission of Hubei Province, Wuhan, Hubei, ChinaDepartment of Obstetrics and Gynecology, National Clinical Research Center for Obstetrics and Gynecology, Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, ChinaDepartment of Obstetrics and Gynecology, National Clinical Research Center for Obstetrics and Gynecology, Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, ChinaObjective To evaluate the hospitalised patients with uterine fibroids (UFs) and describe treatment patterns in hospital-treated patients in central China from 2018 to 2021.Design A retrospective analysis.Setting The gynaecology departments of class A and class B secondary and tertiary hospitals in Hubei Province, China.Participants 101 008 patients diagnosed with UFs from 1 January 2018 to 31 December 2021.Results The hospitalised patients with UFs increased with age, reaching a peak at ages 45–49 years and then gradually decreasing. Among these patients, 19.05% had anaemia symptoms. Women aged 25–29 years were more likely to be treated with laparoscopic myomectomy (62.22%), while women aged 20–24 years tend to choose open myomectomy (34.58%). Women over age 45 years who had entered perimenopause tended to be treated with laparoscopic hysterectomy (64.85% for those aged 65–69 years). Patients with fibroid with moderate-to-severe anaemia mostly chose hysterectomy. As a whole, the proportion of patients who chose laparoscopic hysterectomy was similar to that of patients who chose laparoscopic myomectomy (31.38% vs 31.14%). Only 2.08% of UFs were treated with high-frequency MRI-guided focused ultrasound surgery (MRgFUS). The number of patients who choose laparoscopic surgery or MRgFUS treatment was increasing year by year. After stratifying by hospital grade, we found that women treated at class A tertiary hospitals were more likely to have laparoscopic than open surgery (66.12% vs 31.26%). At class B secondary hospitals, 61.9% of the patients underwent myomectomy. By contrast, hysterectomy was used to treat the majority of patients at class A secondary hospitals and class B tertiary hospitals (57.79% and 57.57%, respectively). Use of MRgFUS was mainly concentrated within class A tertiary hospitals.Conclusion UFs affect mainly women in childbearing period. Most patients chose to receive treatment at class A tertiary hospitals, among which laparoscopic myomectomy was the mainstream surgical method for patients in Hubei Province.Trial registration number NCT05840042.https://bmjopen.bmj.com/content/14/1/e081736.full
spellingShingle Wei Yan
Shixuan Wang
Minli Zhang
Wenwen Wang
Da Zhou
Suzhen Yuan
Shuhao Yang
Status and treatment of patients with uterine fibroids in hospitals in central China: a retrospective study from 2018 to 2021
BMJ Open
title Status and treatment of patients with uterine fibroids in hospitals in central China: a retrospective study from 2018 to 2021
title_full Status and treatment of patients with uterine fibroids in hospitals in central China: a retrospective study from 2018 to 2021
title_fullStr Status and treatment of patients with uterine fibroids in hospitals in central China: a retrospective study from 2018 to 2021
title_full_unstemmed Status and treatment of patients with uterine fibroids in hospitals in central China: a retrospective study from 2018 to 2021
title_short Status and treatment of patients with uterine fibroids in hospitals in central China: a retrospective study from 2018 to 2021
title_sort status and treatment of patients with uterine fibroids in hospitals in central china a retrospective study from 2018 to 2021
url https://bmjopen.bmj.com/content/14/1/e081736.full
work_keys_str_mv AT weiyan statusandtreatmentofpatientswithuterinefibroidsinhospitalsincentralchinaaretrospectivestudyfrom2018to2021
AT shixuanwang statusandtreatmentofpatientswithuterinefibroidsinhospitalsincentralchinaaretrospectivestudyfrom2018to2021
AT minlizhang statusandtreatmentofpatientswithuterinefibroidsinhospitalsincentralchinaaretrospectivestudyfrom2018to2021
AT wenwenwang statusandtreatmentofpatientswithuterinefibroidsinhospitalsincentralchinaaretrospectivestudyfrom2018to2021
AT dazhou statusandtreatmentofpatientswithuterinefibroidsinhospitalsincentralchinaaretrospectivestudyfrom2018to2021
AT suzhenyuan statusandtreatmentofpatientswithuterinefibroidsinhospitalsincentralchinaaretrospectivestudyfrom2018to2021
AT shuhaoyang statusandtreatmentofpatientswithuterinefibroidsinhospitalsincentralchinaaretrospectivestudyfrom2018to2021